Skip to main content
Top
Published in: Cancer Causes & Control 12/2014

01-12-2014 | Original paper

The risk of breast cancer associated with specific patterns of migraine history

Authors: Sarah J. Lowry, Kathleen E. Malone, Kara L. Cushing-Haugen, Christopher I. Li

Published in: Cancer Causes & Control | Issue 12/2014

Login to get access

Abstract

Purpose

Studies have suggested that a history of migraines may be associated with a lower risk of some types of breast cancer, though biological mechanisms are unclear. Identifying specific characteristics of migraines which are most strongly associated with breast cancer risk could improve our understanding of this relationship.

Methods

We ascertained specific characteristics of women’s migraine histories (severity, timing features, and presence of migraine aura). We used polytomous logistic regression to estimate the risk of ER+ ductal, ER− ductal, ER+ lobular, and ER+ ductal–lobular breast cancer associated with self-reported characteristics of migraine history. A total of 715 breast cancer cases (276 ER+ ductal, 46 ER− ductal, 191 ER+ lobular, and 202 ER+ ductal–lobular) and 376 controls ages 55–74 years were included in this population-based case–control study.

Results

Compared to women without a migraine history, women with a >30-year history of migraines had a 60 % (95 % CI 0.2–0.6) lower risk of ER+ ductal breast cancer; those who had their first migraine before age 20 had 50 % lower risks of ER+ ductal and ER+ lobular breast cancer (both 95 % CIs 0.3–0.9), and women who experienced migraine with aura had 30 % (95 % CI 0.5–0.98) and 40 % (95 % CI 0.4–0.9) lower risks of ER+ ductal and ER+ lobular breast cancer, respectively.

Conclusion

The lower risk of ER+ breast cancer associated with migraine appears to be limited to those women with early onset or long duration of migraine history, or those who experienced migraine with aura. This expands our understanding of the relationship between migraine and breast cancer and provides additional insight into potential underlying biological mechanisms.
Literature
2.
go back to reference Li CI, Mathes RW, Malone KE, Daling JR, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Deapen D, Burkman RT, Folger SG, McDonald JA, Spirtas R (2009) Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 18(7):2030–2034. doi:10.1158/1055-9965.EPI-09-0291 PubMedCentralPubMedCrossRef Li CI, Mathes RW, Malone KE, Daling JR, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Deapen D, Burkman RT, Folger SG, McDonald JA, Spirtas R (2009) Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 18(7):2030–2034. doi:10.​1158/​1055-9965.​EPI-09-0291 PubMedCentralPubMedCrossRef
5.
go back to reference Dumitrescu RG, Cotarla I (2005) Understanding breast cancer risk—Where do we stand in 2005? J Cell Mol Med 9(1):208–221PubMedCrossRef Dumitrescu RG, Cotarla I (2005) Understanding breast cancer risk—Where do we stand in 2005? J Cell Mol Med 9(1):208–221PubMedCrossRef
8.
go back to reference Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB (2013) Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. doi:10.1111/head.12150 Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB (2013) Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. doi:10.​1111/​head.​12150
12.
go back to reference Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR (2008) Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal–lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev 17(1):43–50. doi:10.1158/1055-9965.EPI-07-0558 PubMedCrossRef Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR (2008) Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal–lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev 17(1):43–50. doi:10.​1158/​1055-9965.​EPI-07-0558 PubMedCrossRef
15.
go back to reference Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160 Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160
16.
go back to reference Bernstein L (2002) Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7(1):3–15PubMedCrossRef Bernstein L (2002) Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7(1):3–15PubMedCrossRef
26.
go back to reference Kudo C, Haerter K, Moskowitz MA, Ayata C (2006) Estrogen modulates the susceptibility to cortical spreading depression, in vivo. Paper presented at the Society for Neuroscience, Atlanta, GA, 17 October 2006 Kudo C, Haerter K, Moskowitz MA, Ayata C (2006) Estrogen modulates the susceptibility to cortical spreading depression, in vivo. Paper presented at the Society for Neuroscience, Atlanta, GA, 17 October 2006
27.
go back to reference Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O’Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R (2010) Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study. J Natl Cancer Inst 102(18):1422–1431. doi:10.1093/jnci/djq316 PubMedCentralPubMedCrossRef Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O’Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R (2010) Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study. J Natl Cancer Inst 102(18):1422–1431. doi:10.​1093/​jnci/​djq316 PubMedCentralPubMedCrossRef
28.
go back to reference Coronado GD, Beasley J, Livaudais J (2011) Alcohol consumption and the risk of breast cancer. Salud Publica Mex 53(5):440–447PubMed Coronado GD, Beasley J, Livaudais J (2011) Alcohol consumption and the risk of breast cancer. Salud Publica Mex 53(5):440–447PubMed
29.
go back to reference Kabat GC, Kim M, Phipps AI, Li CI, Messina CR, Wactawski-Wende J, Kuller L, Simon MS, Yasmeen S, Wassertheil-Smoller S, Rohan TE (2011) Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women. Cancer Causes Control 22(5):775–783. doi:10.1007/s10552-011-9750-7 PubMedCentralPubMedCrossRef Kabat GC, Kim M, Phipps AI, Li CI, Messina CR, Wactawski-Wende J, Kuller L, Simon MS, Yasmeen S, Wassertheil-Smoller S, Rohan TE (2011) Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women. Cancer Causes Control 22(5):775–783. doi:10.​1007/​s10552-011-9750-7 PubMedCentralPubMedCrossRef
Metadata
Title
The risk of breast cancer associated with specific patterns of migraine history
Authors
Sarah J. Lowry
Kathleen E. Malone
Kara L. Cushing-Haugen
Christopher I. Li
Publication date
01-12-2014
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 12/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0479-y

Other articles of this Issue 12/2014

Cancer Causes & Control 12/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine